chronic kidney disease
Conditions
Interventions
Experimental observation group:tetramethylpyrazine combined with Bupi Yishen Heat-sensitive Moxibustion
Control group:tetramethylpyrazine
Sponsors
Jiujiang Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ?patients with chronic kidney disease and CKD1-3 stage (GFR = 30 mL / min), ?patients with spleen-kidney yang deficiency and blood stasis syndrome, ?patients aged between 18 and 65 years old, ?patients who were willing to take part in the test and sign the informed consent form.
Exclusion criteria
Exclusion criteria: ?mentally ill patient who do not sign the informed consent form ?life-threatening diseases of other systems ?patients who are subject to relevant treatment that may affect the effect of this test, ?patients with other organ failure who have obvious bleeding ?pregnant or lactating women or patients with excessive menstruation, ?patients with allergies and allergies to multiple drugs, ?coma patients, sensory disorders, and advanced tumor patients, ?patients with hematological diseases, skin ulcers or lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| estimated glomerular filtration rate;serum creatinine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cystain;24-hour urine protein;ß2-microglobulin;blood urea nitrogen;Fibrinogen;hemoglobin;red blood cell;plasma albumin; | — |
Countries
China
Contacts
Public ContactXuefei Lin
Outcome results
None listed